Document is current
Any future updates will be listed below
-
Authors
Sforzini, Luca https://orcid.org/0000-0001-6795-0391
Cattaneo, Annamaria https://orcid.org/0000-0002-9963-848X
Ferrari, Clarissa
Turner, Lorinda
Mariani, Nicole https://orcid.org/0000-0001-7918-3492
Enache, Daniela https://orcid.org/0000-0003-4684-9352
Hastings, Caitlin
Lombardo, Giulia
Nettis, Maria A. https://orcid.org/0000-0002-5401-8391
Nikkheslat, Naghmeh
Worrell, Courtney https://orcid.org/0000-0003-0539-2376
Zajkowska, Zuzanna https://orcid.org/0000-0002-5214-305X
Kose, Melisa
Cattane, Nadia
Lopizzo, Nicola
Mazzelli, Monica
Pointon, Linda https://orcid.org/0000-0003-2738-8589
Cowen, Philip J. https://orcid.org/0000-0001-5518-6138
Cavanagh, Jonathan https://orcid.org/0000-0003-0640-8050
Harrison, Neil A. https://orcid.org/0000-0002-9584-3769
Jones, Declan
Drevets, Wayne C.
Mondelli, Valeria https://orcid.org/0000-0001-8690-6839
Bullmore, Edward T.
,
Mondelli, Valeria
Pariante, Carmine M.
Pariante, Carmine M. https://orcid.org/0000-0002-9132-5091
-
Funding
Funding for this research was provided by:
Wellcome Trust (104025, 104025)
- License Information
-
More Information
Article History
Received: 5 October 2022
Revised: 14 April 2023
Accepted: 19 April 2023
First Online: 1 June 2023
Competing interests
: The authors declare that they have no known conflict of interest that could have appeared to influence the work reported in this paper. Prof. Pariante have received research funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2, as part of the EU-PEARL project. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Prof. Pariante is also funded by a Senior Investigator award from the National Institute for Health Research (NIHR); the Medical Research Council (grants MR/L014815/1, MR/J002739/1 and MR/N029488/1); the European Commission (EARLYCAUSE grant SC1-BHC-01-2019); the NARSAD; the Psychiatry Research Trust; and the Wellcome Trust (SHAPER, Scaling-up Health-Arts Programme to scale up arts interventions, grant 219425/Z/19/Z). Less than 10% of his support in the last 10 years derives from commercial collaborations, including consultation and speakers fees from Boehringer Ingelheim, Eli Lilly, Compass, Eleusis, GH Research, Lundbeck, and Värde Partners. Dr Mondelli is also funded by MQ: Transforming Mental Health (Grant: MQBF/1 and MQBF/4) and the Medical Research Foundation (Grant: MRF-160-0005-ELP-MONDE).
